Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair<sup>®</sup> versus HandiHaler<sup>®</sup> in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.